Ma'ale'ale Fa'atatau: 96.97%(95%CI:83.35%～99.99%)
Tulaga Fa'apitoa: 100.00%（95%CI：97.29%～100.00%）
Sa'o: 99.50%(95%CI:96.94%～99.99%)
I'uga vave ile 15-30 minute Rapid antigen kit AMRDT120
O se su'ega vave mo le su'esu'eina lelei o le fa'aituau
antibodies i le SARS-CoV-2 poʻo ana tui i le toto atoa, serum, poʻo le plasma.
Fa'amatalaga Fa'amatalaga: 40 T/kit, 20 T/kit, 10 T/kit, 1 T/kit.
Ma'ale'ale Fa'atatau: 96.97%(95%CI:83.35%～99.99%)
Tulaga Fa'apitoa: 100.00%（95%CI：97.29%～100.00%）
Sa'o: 99.50%(95%CI:96.94%～99.99%)
O taga iila, ma kaseti su'esu'e ma mea fa'amama *20
Su'e su'ega *20 fagu;
Fa'apa'u fa'aaoga*20;
Lancet *20
Lodine swab*20
Fa'atonuga mo le fa'aoga*1
Fa'ai'uga vave ile 15-30 minute Rapid antigen kit AMRDT120 FA'AOGAINA
O le SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) o se chromatographic immunoassay vave mo le suʻesuʻeina lelei o faʻamaʻi faʻamaʻi i le SARS-CoV-2 i le toto atoa, serum, poʻo le plasma.
Fa'ai'uga vave ile 15-30 minute Rapid antigen kit AMRDT120 PRINCIPLE
O le SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) e mo le sailia o antibodies i le SARS-CoV-2 poʻo ana tui.O le su'esu'ega i luga o le sela o le angiotensin converting enzyme-2 (ACE2) o lo'o ufiufi i le laina o su'ega ma le recombinant receptor-binding domain (RBD) fa'atasi ma vaega fa'aalia.
I le taimi o suʻega, afai o loʻo i ai SARS-CoV-2 faʻamaʻi faʻamaʻi i totonu o le faʻataʻitaʻiga, o le a tali atu i le protein RBD-particle conjugate ae le tali atu i le protein ACE2 ua uma ona ufiufi.O le paluga e alu i luga i luga o le membrane chromatographically e ala i le gaioiina o capillary ma e le mafai ona puʻeina e le antigen ua uma ona ufiufi.O le SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) o loʻo i ai ni polotini e ufiufi RBD.Ole polotini ACE2 o lo'o ufiufi ile vaega ole laina ole su'ega.
